Global Biopharmaceutical Contract Manufacturing Market Size, Status and Forecast 2019-2025

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Biopharmaceutical Contract Manufacturing Revenue
• 1.4 Market by Type
  • 1.4.1 Global Biopharmaceutical Contract Manufacturing Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Growth Factors
  • 1.4.3 Interferons
  • 1.4.4 Monoclonal Antibodies
  • 1.4.5 Recombinant Hormones
  • 1.4.6 Vaccines
  • 1.4.7 Insulin
  • 1.4.8 Others
• 1.5 Market by Application
  • 1.5.1 Global Biopharmaceutical Contract Manufacturing Market Share by Application: 2020 VS 2026
  • 1.5.2 Autoimmune Diseases
  • 1.5.3 Oncology
  • 1.5.4 Metabolic Diseases
  • 1.5.5 Ophthalmology
  • 1.5.6 Cardiovascular Diseases
  • 1.5.7 Infectious Diseases
  • 1.5.8 Neurology
  • 1.5.9 Respiratory Disorders
  • 1.5.10 Others
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Global Biopharmaceutical Contract Manufacturing Market Perspective (2015-2026)
• 2.2 Global Biopharmaceutical Contract Manufacturing Growth Trends by Regions
  • 2.2.1 Biopharmaceutical Contract Manufacturing Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Biopharmaceutical Contract Manufacturing Historic Market Share by Regions (2015-2020)
  • 2.2.3 Biopharmaceutical Contract Manufacturing Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Biopharmaceutical Contract Manufacturing Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Biopharmaceutical Contract Manufacturing Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Biopharmaceutical Contract Manufacturing Players by Market Size
  • 3.1.1 Global Top Biopharmaceutical Contract Manufacturing Players by Revenue (2015-2020)
  • 3.1.2 Global Biopharmaceutical Contract Manufacturing Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Biopharmaceutical Contract Manufacturing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Biopharmaceutical Contract Manufacturing Market Concentration Ratio
  • 3.2.1 Global Biopharmaceutical Contract Manufacturing Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Biopharmaceutical Contract Manufacturing Revenue in 2019
• 3.3 Biopharmaceutical Contract Manufacturing Key Players Head office and Area Served
• 3.4 Key Players Biopharmaceutical Contract Manufacturing Product Solution and Service
• 3.5 Date of Enter into Biopharmaceutical Contract Manufacturing Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

• 4.1 Global Biopharmaceutical Contract Manufacturing Historic Market Size by Type (2015-2020)
• 4.2 Global Biopharmaceutical Contract Manufacturing Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

• 5.1 Global Biopharmaceutical Contract Manufacturing Market Size by Application (2015-2020)
• 5.2 Global Biopharmaceutical Contract Manufacturing Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Biopharmaceutical Contract Manufacturing Market Size (2015-2020)
• 6.2 Biopharmaceutical Contract Manufacturing Key Players in North America (2019-2020)
• 6.3 North America Biopharmaceutical Contract Manufacturing Market Size by Type (2015-2020)
• 6.4 North America Biopharmaceutical Contract Manufacturing Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Biopharmaceutical Contract Manufacturing Market Size (2015-2020)
• 7.2 Biopharmaceutical Contract Manufacturing Key Players in Europe (2019-2020)
• 7.3 Europe Biopharmaceutical Contract Manufacturing Market Size by Type (2015-2020)
• 7.4 Europe Biopharmaceutical Contract Manufacturing Market Size by Application (2015-2020)

8 China

• 8.1 China Biopharmaceutical Contract Manufacturing Market Size (2015-2020)
• 8.2 Biopharmaceutical Contract Manufacturing Key Players in China (2019-2020)
• 8.3 China Biopharmaceutical Contract Manufacturing Market Size by Type (2015-2020)
• 8.4 China Biopharmaceutical Contract Manufacturing Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Biopharmaceutical Contract Manufacturing Market Size (2015-2020)
• 9.2 Biopharmaceutical Contract Manufacturing Key Players in Japan (2019-2020)
• 9.3 Japan Biopharmaceutical Contract Manufacturing Market Size by Type (2015-2020)
• 9.4 Japan Biopharmaceutical Contract Manufacturing Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Biopharmaceutical Contract Manufacturing Market Size (2015-2020)
• 10.2 Biopharmaceutical Contract Manufacturing Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Biopharmaceutical Contract Manufacturing Market Size by Type (2015-2020)
• 10.4 Southeast Asia Biopharmaceutical Contract Manufacturing Market Size by Application (2015-2020)

11 India

• 11.1 India Biopharmaceutical Contract Manufacturing Market Size (2015-2020)
• 11.2 Biopharmaceutical Contract Manufacturing Key Players in India (2019-2020)
• 11.3 India Biopharmaceutical Contract Manufacturing Market Size by Type (2015-2020)
• 11.4 India Biopharmaceutical Contract Manufacturing Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Biopharmaceutical Contract Manufacturing Market Size (2015-2020)
• 12.2 Biopharmaceutical Contract Manufacturing Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Biopharmaceutical Contract Manufacturing Market Size by Type (2015-2020)
• 12.4 Central & South America Biopharmaceutical Contract Manufacturing Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Lonza Group
  • 13.1.1 Lonza Group Company Details
  • 13.1.2 Lonza Group Business Overview
  • 13.1.3 Lonza Group Biopharmaceutical Contract Manufacturing Introduction
  • 13.1.4 Lonza Group Revenue in Biopharmaceutical Contract Manufacturing Business (2015-2020))
  • 13.1.5 Lonza Group Recent Development
• 13.2 Baxter Biopharma Solutions
  • 13.2.1 Baxter Biopharma Solutions Company Details
  • 13.2.2 Baxter Biopharma Solutions Business Overview
  • 13.2.3 Baxter Biopharma Solutions Biopharmaceutical Contract Manufacturing Introduction
  • 13.2.4 Baxter Biopharma Solutions Revenue in Biopharmaceutical Contract Manufacturing Business (2015-2020)
  • 13.2.5 Baxter Biopharma Solutions Recent Development
• 13.3 Samsung
  • 13.3.1 Samsung Company Details
  • 13.3.2 Samsung Business Overview
  • 13.3.3 Samsung Biopharmaceutical Contract Manufacturing Introduction
  • 13.3.4 Samsung Revenue in Biopharmaceutical Contract Manufacturing Business (2015-2020)
  • 13.3.5 Samsung Recent Development
• 13.4 Fujifilm Diosynth Biotechnologies
  • 13.4.1 Fujifilm Diosynth Biotechnologies Company Details
  • 13.4.2 Fujifilm Diosynth Biotechnologies Business Overview
  • 13.4.3 Fujifilm Diosynth Biotechnologies Biopharmaceutical Contract Manufacturing Introduction
  • 13.4.4 Fujifilm Diosynth Biotechnologies Revenue in Biopharmaceutical Contract Manufacturing Business (2015-2020)
  • 13.4.5 Fujifilm Diosynth Biotechnologies Recent Development
• 13.5 Boehringer Ingelheim
  • 13.5.1 Boehringer Ingelheim Company Details
  • 13.5.2 Boehringer Ingelheim Business Overview
  • 13.5.3 Boehringer Ingelheim Biopharmaceutical Contract Manufacturing Introduction
  • 13.5.4 Boehringer Ingelheim Revenue in Biopharmaceutical Contract Manufacturing Business (2015-2020)
  • 13.5.5 Boehringer Ingelheim Recent Development
• 13.6 Patheon
  • 13.6.1 Patheon Company Details
  • 13.6.2 Patheon Business Overview
  • 13.6.3 Patheon Biopharmaceutical Contract Manufacturing Introduction
  • 13.6.4 Patheon Revenue in Biopharmaceutical Contract Manufacturing Business (2015-2020)
  • 13.6.5 Patheon Recent Development
• 13.7 Rentschler Biotechnologie
  • 13.7.1 Rentschler Biotechnologie Company Details
  • 13.7.2 Rentschler Biotechnologie Business Overview
  • 13.7.3 Rentschler Biotechnologie Biopharmaceutical Contract Manufacturing Introduction
  • 13.7.4 Rentschler Biotechnologie Revenue in Biopharmaceutical Contract Manufacturing Business (2015-2020)
  • 13.7.5 Rentschler Biotechnologie Recent Development
• 13.8 Biomeva
  • 13.8.1 Biomeva Company Details
  • 13.8.2 Biomeva Business Overview
  • 13.8.3 Biomeva Biopharmaceutical Contract Manufacturing Introduction
  • 13.8.4 Biomeva Revenue in Biopharmaceutical Contract Manufacturing Business (2015-2020)
  • 13.8.5 Biomeva Recent Development
• 13.9 Probiogen
  • 13.9.1 Probiogen Company Details
  • 13.9.2 Probiogen Business Overview
  • 13.9.3 Probiogen Biopharmaceutical Contract Manufacturing Introduction
  • 13.9.4 Probiogen Revenue in Biopharmaceutical Contract Manufacturing Business (2015-2020)
  • 13.9.5 Probiogen Recent Development
• 13.10 Cytovance Biologics
  • 13.10.1 Cytovance Biologics Company Details
  • 13.10.2 Cytovance Biologics Business Overview
  • 13.10.3 Cytovance Biologics Biopharmaceutical Contract Manufacturing Introduction
  • 13.10.4 Cytovance Biologics Revenue in Biopharmaceutical Contract Manufacturing Business (2015-2020)
  • 13.10.5 Cytovance Biologics Recent Development
• 13.11 KBI Biopharma
  • 10.11.1 KBI Biopharma Company Details
  • 10.11.2 KBI Biopharma Business Overview
  • 10.11.3 KBI Biopharma Biopharmaceutical Contract Manufacturing Introduction
  • 10.11.4 KBI Biopharma Revenue in Biopharmaceutical Contract Manufacturing Business (2015-2020)
  • 10.11.5 KBI Biopharma Recent Development
• 13.12 WuXi Biologics
  • 10.12.1 WuXi Biologics Company Details
  • 10.12.2 WuXi Biologics Business Overview
  • 10.12.3 WuXi Biologics Biopharmaceutical Contract Manufacturing Introduction
  • 10.12.4 WuXi Biologics Revenue in Biopharmaceutical Contract Manufacturing Business (2015-2020)
  • 10.12.5 WuXi Biologics Recent Development
• 13.13 Abzena
  • 10.13.1 Abzena Company Details
  • 10.13.2 Abzena Business Overview
  • 10.13.3 Abzena Biopharmaceutical Contract Manufacturing Introduction
  • 10.13.4 Abzena Revenue in Biopharmaceutical Contract Manufacturing Business (2015-2020)
  • 10.13.5 Abzena Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer